Removal of antimicrobials using advanced wastewater treatment

Journal of Hazardous Materials

Volumn 192, Issue 1, 2011, Pages 319-328

  Senta, Ivan ^a   Matošić, Marin ^b   Jakopović, Helena Korajlija ^b   Terzic, Senka ^a   Ćurko, Josip ^b   Mijatović, Ivan ^b   Ahel, Marijan ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Membrane bioreactor; Nanofiltration; Ozonation; Pharmaceuticals; Reverse osmosis

Indexed keywords

ADVANCED TREATMENT; AQUEOUS PHASE; ELIMINATION RATE; FLUOROQUINOLONES; HIGH CONCENTRATION; HYDRAULIC RETENTION TIME; INDUSTRIAL EFFLUENT; INDUSTRIAL WASTEWATERS; MACROLIDES; MASS BALANCE; MEMBRANE BIOREACTOR; MICROBIAL TRANSFORMATION; ORGANIC LOAD; OZONATION PRODUCTS; PHARMACEUTICAL INDUSTRY; SYNTHETIC WASTE WATER; TOTAL NITROGEN; TRIMETHOPRIM;

ADSORPTION; AMIDES; BIOREACTORS; EFFLUENTS; INDUSTRY; NANOFILTRATION; OSMOSIS; OZONE; OZONE WATER TREATMENT; OZONIZATION; REVERSE OSMOSIS; SEWAGE; SULFUR COMPOUNDS; THERMOMECHANICAL PULPING PROCESS; WASTEWATER; WASTEWATER TREATMENT; WATER FILTRATION; WATER TREATMENT PLANTS;

INDUSTRIAL WATER TREATMENT;

INDUSTRIAL EFFLUENT; MACROLIDE; NITROGEN; QUINOLONE DERIVATIVE; SULFONAMIDE; TRIMETHOPRIM;

ADSORPTION; ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BIOREACTOR; CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; MASS BALANCE; MICROBIAL ACTIVITY; ORGANIC MATTER; OSMOSIS; OZONE; PERFORMANCE ASSESSMENT; POLLUTANT REMOVAL; SLUDGE; ULTRAFILTRATION; WASTE TREATMENT; WASTEWATER; WATER POLLUTION; WATER RETENTION; WATER TREATMENT;

ADSORPTION KINETICS; AQUEOUS SOLUTION; ARTICLE; BACTERIUM TRANSFORMATION; ELIMINATION REACTION; GLACIAL MASS BALANCE; MEMBRANE REACTOR; NANOFILTRATION; OZONATION; REVERSE OSMOSIS; SLUDGE; WASTE WATER MANAGEMENT;

ANTI-INFECTIVE AGENTS; OSMOSIS; WATER POLLUTANTS, CHEMICAL;

EID: 79959698676     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2011.05.021     Document Type: Article

References (39)

1. Richardson S.D. Water analysis: emerging contaminants and current issues. Anal. Chem. 2009, 81:4645-4677.
2. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
3. Segura P.A., Francois M., Gagnon C., Sauve S. Review of the occurrence of anti-infectives in contaminated wastewaters and natural and drinking waters. Environ. Health Perspect. 2009, 117:675-684.
4. Zhang X.X., Zhang T., Fang H. Antibiotic resistance genes in water environment. Appl. Microbiol. Biotechnol. 2009, 82:397-414.
5. da Costa P.M., Vaz-Pires P., Bernardo F. Antimicrobial resistance in Enterococcus spp. isolated in inflow, effluent and sludge from municipal sewage water treatment plants. Water Res. 2006, 40:1735-1740.
6. Watkinson A.J, Murby E.J., Costanzo S.D. Removal of antibiotics in conventional and advanced wastewater treatment: implications for environmental discharge and wastewater recycling. Water Res. 2007, 41:4164-4176.
7. Abegglen C., Joss A., McArdell C.S., Fink G., Schlüsener M.P., Ternes T.A., Siegrist H. The fate of selected micropollutants in a single-house MBR. Water Res. 2009, 43:2036-2046.
8. Radjenović J., Petrović M., Ventura F., Barcelo D. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res. 2008, 42:3601-3610.
9. Ikehata K., Naghashkar N.J., El-Din M.G. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone: Sci. Eng. 2006, 28:353-414.
10. Terzic S., Matosic M., Ahel M., Mijatovic I. Elimination of aromatic surfactants from municipal wastewaters: comparison of conventional activated sludge treatment and membrane biological reactor. Water Sci. Technol. 2003, 51:447-453.
11. Radjenović J., Petrović M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43:831-841.
12. Le-Minh N., Coleman H.M., Khan S.J., van Luer Y., Trang T.T.T., Watkins G., Stuetz R.M. The application of membrane bioreactors as decentralized systems for removal of endocrine disrupting chemicals and pharmaceuticals. Water Sci. Technol. 2010, 61:1081-1088.
13. Sipma J., Osuna B., Collado N., Monclus H., Ferrero G., Comas J., Rodriguez-Roda I. Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination 2010, 250:653-659.
14. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39:4797-4807.
15. Göbel A, McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372:361-371.
16. Wagner J., Rosenwinkel K.H. Sludge production in membrane bioreactors under different conditions. Water Sci. Technol. 2000, 41:251-258.
17. Reif R., Suarez S., Omil F., Lema J.M. Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage. Desalination 2008, 221:511-517.
18. Fane A.G., Fane S.A. The role of membrane technology in sustainable decentralized wastewater systems. Water Sci. Technol. 2005, 51:317-325.
19. Matosic M., Terzic S., Korajlija Jakopovic H., Mijatovic I., Ahel M. Treatment of a landfill leachate containing compounds of pharmaceutical origin. Water Sci. Technol. 2008, 58:597-602.
20. Ternes T.A., Stüber J., Herrmann N., McDowell D., Ried A., Kampmann M., Teiser B. Ozonation: a toll for removal of pharmaceuticals, contrast media and musk fregrances from wastewater?. Water Res. 2003, 37:1976-1982.
21. Lin A.Y.C., Lin C.F., Chiou J.M., Hong P.K.A. O3 and O3/H2O2 treatment of sulfonamide and macrolide antibiotics in wastewater. J. Hazard. Mater. 2009, 171:452-458.
22. Larsson D.G.J., de Pedro C., Paxeus N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazard. Mater. 2007, 148:751-755.
23. I. Senta, Occurrence and behaviour of sulfonamides, fluoroquinolones, macrolides and trimethoprim in wastewater and natural water, PhD thesis, Zagreb, 2009, pp. 120.
24. Terzić S., Senta I., Ahel M., Gros M., Petrović M., Barcelo D., Müller J., Knepper T., Martí I., Ventura F., Jovančić P., Jabučar D. Occurrence and fate of emerging wastewater contaminants in Western Balkan Region. Sci. Total Environ. 2008, 399:66-77.
25. Standard Methods for the Examination of Water and Wastewater, APHA-AWWA-WPCF, Washington D.C. (1992).
26. Senta I., Terzic S., Ahel M. Simultaneous determination of sulfonamides, fluoroquinolones, macrolides and trimethoprim in wastewater and river water by LC-tandem-MS. Chromatographia 2008, 68:747-758.
27. Curlin M, Matic M., Matosic M., Mijatovic I., Kurtanjek Z. Effects of hydraulic residence time and mixing on wastewater treatment in a membrane bioreactor. Chem. Biochem. Eng. Q. 2004, 18:97-104.
28. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 2007, 41:1013-1021.
29. Tambosi J.L, de Sena R.F., Favier M., Gebhardt W., Jose H.J., Schroeder H.F., Muniz Moreira R.P. Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged membranes. Desalination 2010, 261:148-156.
30. Suarez S., Lema J.M., Omil F. Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res. 2010, 44:3214-3224.
31. Golet E.M., Xifra I., Siegrist H., Alder A.C., Giger W. Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environ. Sci. Technol. 2003, 37:3243-3249.
32. Batt A.L., Kim S., Aga D.S. Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge. Environ. Sci. Technol. 2006, 40:7367-7373.
33. Rosenberger S., Krüger U., Witzig R., Manz W., Szewzyk U., Kraume M. Performance of a bioreactor with submerged membranes for aerobic treatment of municipal waste water. Water Res. 2002, 36:413-420.
34. Pollice A., Laera G., Blonda M. Biomass growth and activity in a membrane bioreactor with complete sludge retention. Water Res. 2004, 38:1799-1808.
35. Xu W., Zhang G., Li X., Zou S., Li P., Hu Z., Li J. Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. Water Res. 2007, 41:4526-4534.
36. Flyborg L., Bjorlenius B., Persson K.M. Can treated municipal wastewater be reused after ozonation and nanofiltration? Results from a pilot study of pharmaceutical removal in Henriksdal WWTP, Sweden. Water Sci. Technol. 2010, 61:1113-1120.
37. Lange F., Cornelissen S., Kubac D., Sein M.M., von Sonntag J., Hannich C.B., Golloch A., Heipieper H.J., Möder M., von Sonntag C. Degradation of macrolide antibiotics by ozone: a mechanistic case study with clarithromycin. Chemosphere 2006, 65:17-23.
38. DeWitte B., Dewulf J., Demeestere K., Van de Vyvere V., De Wispelaere P., Van Langenhove H. Ozonation of ciprofloxacin in water: HRMS identification of reaction products and pathways. Environ. Sci. Technol. 2008, 42:4889-4895.
39. Radjenović J., Godehardt M., Petrović M., Hein A., Farre M., Jekel M., Barcelo D. Evidencing generation of persistent ozonation products of antibiotics roxithromycin and trimethoprim. Environ. Sci. Technol. 2009, 43:6808-6815.